1.Comparison of Erectile Response to Intracavernous Injection Therapy in Diabetic and Non-diabetic Erectile Dysfunction Patients.
Ok Roung JANG ; Jae Il KIM ; Seok San PARK
Korean Journal of Urology 2000;41(3):425-429
No abstract available.
Erectile Dysfunction*
;
Humans
;
Male
2.Dynamic infusion cavernosometry and cavernosography(DICC).
Korean Journal of Urology 1991;32(4):649-656
During the last several years, cavernosography has been commonly used to demonstrate the hemodynemic abnormality of the corpora cavernosa. But this was recognized as a less obvious, physiologic and objective study. Recently a more ideal method has been introduced and resulted in the development of the procedure entitle Dynamic Infusion Cavernosometry and Cavernosography ( DICC). The DICC is done in four phase :phase I involves the determination of equilibrium corporeal body pressure and time required to reach the plateau. Phase S involves the determination of the rate of fall of corporal body pressure from a control pressure (150mmHg) over a defined observation period (30 seconds). Phase III involves the determination of cavernosal arterial systolic occlusion pressure and finally phase IV involves the cavernosography at a predetermined corporael body pressure (90mmHg). Now, this procedure is performed as the first invasive erectile function test in those individuals considered for vascular reconstruction of their erectile problem.
Erectile Dysfunction
;
Male
3.Dynamic infusion cavernosometry and cavernosography(DICC).
Korean Journal of Urology 1991;32(4):649-656
During the last several years, cavernosography has been commonly used to demonstrate the hemodynemic abnormality of the corpora cavernosa. But this was recognized as a less obvious, physiologic and objective study. Recently a more ideal method has been introduced and resulted in the development of the procedure entitle Dynamic Infusion Cavernosometry and Cavernosography ( DICC). The DICC is done in four phase :phase I involves the determination of equilibrium corporeal body pressure and time required to reach the plateau. Phase S involves the determination of the rate of fall of corporal body pressure from a control pressure (150mmHg) over a defined observation period (30 seconds). Phase III involves the determination of cavernosal arterial systolic occlusion pressure and finally phase IV involves the cavernosography at a predetermined corporael body pressure (90mmHg). Now, this procedure is performed as the first invasive erectile function test in those individuals considered for vascular reconstruction of their erectile problem.
Erectile Dysfunction
;
Male
4.Recent Advance in Medical Treatment of Erectile Dysfunction.
Journal of Korean Society of Endocrinology 1998;13(2):137-144
No abstract available.
Erectile Dysfunction*
;
Male
5.Surgical Treatment of Male Erectile Dysfunction.
Journal of the Korean Medical Association 1999;42(2):138-144
No abstract available.
Erectile Dysfunction*
;
Humans
;
Male*
6.Medical Treatment of Erectile Dysfunction.
Journal of the Korean Medical Association 1998;41(7):773-782
No abstract available.
Erectile Dysfunction*
;
Male
7.Current management of erectile dysfunction
Pharmaceutical Journal 2005;354(10):33-35
Nowadays enlargement of information helped patients with erectile dysfunction to seek easily suitable treatment. Although there are not optimal method for the disease yet, but there were many important progress specially enzyme inhibitor PDE-5. Vardenafil has more advantages than PDE-5 because of its efficacy and indications. Although non-specific treatments (by oral drug, injection, surgery) have effect in most of erectile dysfunction but it is necessary to use specific treatments (sexual mentality consultancy, endocrine therapy…) for patients, too. Surgery plays important role in the treatment of erectile dysfunction
Erectile Dysfunction
;
Therapeutics
8.Current pharmacological treatments of erectile dysfunction
Ho Chi Minh city Medical Association 2005;10(4):227-228
Summarize some erectile dysfunction drugs which are current popular used, includes: drugs affected to central nerve system as Yohimbine, Apomorphine sublingual tablet; melanindirected peptide; drugs that affected to muscular dilatation of penis such as cavernous injected drugs (Papaverin, Alprostadil), penile suppository drugs, oral drugs (selective inhibition phosphordiesterase-5 (PDE-5) as Sildenafil, Vardenafil, Tadalafil) to prevent hydrolyzing of GMP circle, increase GMP circle’s level in cavernous smooth muscle
Erectile Dysfunction
;
Therapeutics
9.Pharmacological Therapy of Erectile Dysfunction: Current Oral Agents.
Journal of the Korean Academy of Family Medicine 2004;25(4):287-296
No abstract available.
Erectile Dysfunction*
;
Male
10.Intracavernous Self-Injection with Vasoactive Drugs for Erectile Impotence.
Hee Young LEE ; Soo KIM ; Jae Seung PARK
Korean Journal of Urology 1987;28(6):835-848
No abstract available.
Erectile Dysfunction*
;
Male
;
Papaverine